BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi Y, Song R, Wang L, Qi Y, Zhang H, Zhu J, Zhang X, Tang X, Zhan Q, Zhao Y, Swaab DF, Bao A, Zhang Z. Identifying Plasma Biomarkers with high specificity for major depressive disorder: A multi-level proteomics study. Journal of Affective Disorders 2020;277:620-30. [DOI: 10.1016/j.jad.2020.08.078] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ross RE, VanDerwerker CJ, Saladin ME, Gregory CM. The role of exercise in the treatment of depression: biological underpinnings and clinical outcomes. Mol Psychiatry 2023;28:298-328. [PMID: 36253441 DOI: 10.1038/s41380-022-01819-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Fei Wang, Lin Guo, Ting Zhang, Zhiquan Cui, Jinke Wang, Chi Zhang, Fen Xue, Cuihong Zhou, Baojuan Li, Qingrong Tan, Zhengwu Peng. Alterations in Plasma Lipidomic Profiles in Adult Patients with Schizophrenia and Major Depressive Disorder. Medicina (Kaunas) 2022;58:1509. [PMID: 36363466 DOI: 10.3390/medicina58111509] [Reference Citation Analysis]
3 Zhang T, Guo L, Li R, Wang F, Yang W, Yang J, Cui Z, Zhou C, Chen Y, Yu H, Peng Z, Tan Q. Alterations of Plasma Lipids in Adult Women With Major Depressive Disorder and Bipolar Depression. Front Psychiatry 2022;13:927817. [DOI: 10.3389/fpsyt.2022.927817] [Reference Citation Analysis]
4 Shi Y, Zhang L, He C, Yin Y, Song R, Chen S, Fan D, Zhou D, Yuan Y, Xie C, Zhang Z. Sleep disturbance-related neuroimaging features as potential biomarkers for the diagnosis of major depressive disorder: A multicenter study based on machine learning. J Affect Disord 2021;295:148-55. [PMID: 34461370 DOI: 10.1016/j.jad.2021.08.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Song R, Shi Y, Li X, Zhu J, Zhang H, Li K, Wang B, Zhang H, Yang Y, Gao L, Zhao Y, Zhang Z. Potential of Antithrombin III as a Biomarker of Antidepressive Effect in Major Depressive Disorder. Front Psychiatry 2021;12:678384. [PMID: 34777034 DOI: 10.3389/fpsyt.2021.678384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Huan Y, Wei J, Zhou J, Liu M, Yang J, Gao Y. Label-Free Liquid Chromatography-Mass Spectrometry Proteomic Analysis of the Urinary Proteome for Measuring the Escitalopram Treatment Response From Major Depressive Disorder. Front Psychiatry 2021;12:700149. [PMID: 34658947 DOI: 10.3389/fpsyt.2021.700149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Shi Y, Song R, Wang Z, Zhang H, Zhu J, Yue Y, Zhao Y, Zhang Z. Potential clinical value of circular RNAs as peripheral biomarkers for the diagnosis and treatment of major depressive disorder. EBioMedicine 2021;66:103337. [PMID: 33862583 DOI: 10.1016/j.ebiom.2021.103337] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]